43 related articles for article (PubMed ID: 22388163)
1. Model Placental Barrier Phenotypic Response to Fluoxetine and Sertraline: A Comparative Study.
Arumugasaamy N; Gudelsky A; Hurley-Novatny A; Kim PCW; Fisher JP
Adv Healthc Mater; 2019 Sep; 8(18):e1900476. PubMed ID: 31407872
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Ball SE; Ahern D; Scatina J; Kao J
Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
[TBL] [Abstract][Full Text] [Related]
3. CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.
Alfaro CL; Lam YW; Simpson J; Ereshefsky L
J Clin Pharmacol; 2000 Jan; 40(1):58-66. PubMed ID: 10631623
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine-fluoxetine interaction.
Benazzi F
J Clin Psychopharmacol; 1999 Feb; 19(1):96-8. PubMed ID: 9934950
[No Abstract] [Full Text] [Related]
6. Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers.
Liston HL; DeVane CL; Boulton DW; Risch SC; Markowitz JS; Goldman J
J Clin Psychopharmacol; 2002 Apr; 22(2):169-73. PubMed ID: 11910262
[TBL] [Abstract][Full Text] [Related]
7. High venlafaxine serum levels after prior fluoxetine medication.
Gerbaulet M; Engel A; Hiemke C; Dahmen N
J Clin Psychopharmacol; 2012 Apr; 32(2):295-7. PubMed ID: 22388163
[No Abstract] [Full Text] [Related]
8. Antidepressant medication use during breastfeeding.
Lanza di Scalea T; Wisner KL
Clin Obstet Gynecol; 2009 Sep; 52(3):483-97. PubMed ID: 19661763
[TBL] [Abstract][Full Text] [Related]
9. The use of newer antidepressants for panic disorder.
Gorman JM
J Clin Psychiatry; 1997; 58 Suppl 14():54-8; discussion 59. PubMed ID: 9418747
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of SSRI response.
Salzman C
Harv Rev Psychiatry; 1996; 4(4):215-7. PubMed ID: 9384996
[No Abstract] [Full Text] [Related]
11. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
Augustin BG; Cold JA; Jann MW
Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Preskorn SH
J Clin Psychiatry; 1995; 56 Suppl 6():12-21. PubMed ID: 7649968
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
